Skip to Content

Sorafenib Pregnancy and Breastfeeding Warnings

Sorafenib is also known as: Nexavar

Sorafenib Pregnancy Warnings

Animal studies have revealed evidence of embryotoxicity, fetolethality, and teratogenicity. There are no controlled data in human pregnancy. The manufacturer states that based on the proposed mechanism of multikinase inhibition and multiple adverse effects seen in animals at exposure levels significantly below the clinical dose, sorafenib should be assumed to cause fetal harm when administered to a pregnant women.

FDA pregnancy category: D Use of sorafenib should be avoided. Instruct both men and women of childbearing potential to use effective birth control during treatment with sorafenib and for at least 2 weeks after stopping treatment.

See references

Sorafenib Breastfeeding Warnings

Women should be advised against breast-feeding while receiving sorafenib. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Nexavar (sorafenib)." Bayer Pharmaceutical Inc, West Haven, CT.

References for breastfeeding information

  1. "Product Information. Nexavar (sorafenib)." Bayer Pharmaceutical Inc, West Haven, CT.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.